Interestingly, CD69, an additional marker of tissue retention that is also a classic early activation marker, was expressed by both tumor-associated NK-cell subsets, although trNK cells showed significantly higher CD69 frequencies in both patient groups (Supplementary Figure 3). This evidence concerns the gene CD69 and neoplasm.